Quantifying antiepileptic drug effects using intrinsic excitability measures

Area of Science:

• Neuroscience
• Pharmacology
• Biomedical Engineering

Background:

• Epilepsy involves pathological increases in cortical excitability, leading to seizures.
• Antiepileptic drugs (AEDs) aim to reduce neural excitability but can cause dose-dependent adverse effects.
• Quantifying AED effects on brain excitability is crucial for personalized treatment but remains challenging.

Purpose of the Study:

• To investigate the utility of intrinsic excitability measures (IEMs) for quantifying the dose-dependent effects of AEDs on cortical excitability.
• To establish a reliable quantitative measure for monitoring AED pharmacotherapy in epilepsy patients.

Main Methods:

• Systematic analysis of continuous multiday electrocorticography (ECoG) data from 10 epilepsy patients.
• Derivation of IEMs from various brain regions and frequency bands under different AED loads.
• Correlation analysis between IEMs and AED load (prescribed daily dose/defined daily dose).

Main Results:

• Intrinsic excitability measures (IEMs) showed a significant negative correlation with AED load.
• IEMs derived from different brain regions effectively captured global changes in neural excitability.
• These findings suggest IEMs can serve as a quantitative biomarker for AED effects.

Conclusions:

• Intrinsic excitability measures offer a promising quantitative approach to monitor AED pharmacotherapy in epilepsy.
• This method may aid in optimizing AED dosage to minimize adverse effects and improve patient outcomes.
• Further development of IEMs could lead to a reliable tool for assessing central physiologic effects of AEDs.